ICD-9-CM 185 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 185 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
2015/16 ICD-10-CM C61 Malignant neoplasm of prostate
Approximate Synonyms
Adenocarcinoma of prostate
Adenocarcinoma, prostate
CA of prostate
CA prostate, adenoca
CA prostate, primary
Cancer of prostate with metastasis to eye
Cancer of the prostate
Cancer of the prostate with metastasis
Cancer of the prostate, adenocarcinoma
Cancer of the prostate, primary
Cancer of, prostate, hormone refractory
Carcinoma of prostate
Hormone refractory prostate cancer
Metastasis from malignant tumor of prostate
Metastatic prostate cancer
Primary malignant neoplasm of prostate
Prostate cancer
Prostate cancer metastatic to eye
Prostate cancer, hormone refractory
Clinical Information
A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas
The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40. Risk factors for developing prostate cancer include being over 65 years of age, family history, being african-american, and some genetic changes.symptoms of prostate cancer may include
problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling
low back pain
pain with ejaculation
your doctor will diagnose prostate cancer by feeling the prostate through the wall of the rectum or doing a blood test for prostate-specific antigen (psa). Other tests include ultrasound, x-rays, or a biopsy.treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Men with prostate cancer have many treatment options. The treatment that's best for one man may not be best for another. The options include watchful waiting, surgery, radiation therapy, hormone therapy, and chemotherapy. You may have a combination of treatments. nih: national cancer institute